161 related articles for article (PubMed ID: 38566539)
41. The prevalence of human papillomavirus among women in northern Guangdong Province of China.
Huang W; Xu H; Hu H; Zhang D; Liu Y; Guo Y; Xiao F; Chen W; Ma Z
Sci Rep; 2022 Aug; 12(1):13353. PubMed ID: 35922661
[TBL] [Abstract][Full Text] [Related]
42. Chlamydia trachomatis and HPV co-infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies.
Comar M; Monasta L; Seraceni S; Colli C; Luska V; Morassut S; Clemente L; Drabeni M; Moise G; Fontana F; Suligoi B
J Med Virol; 2017 Sep; 89(9):1654-1661. PubMed ID: 28316071
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018.
Ma L; Lei J; Ma L; Cong X; Wang N; Yang H; Liu Q; Yu Y; Cao Y
BMC Infect Dis; 2019 Jul; 19(1):670. PubMed ID: 31357941
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
[TBL] [Abstract][Full Text] [Related]
45. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Patel C; Brotherton JM; Pillsbury A; Jayasinghe S; Donovan B; Macartney K; Marshall H
Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326995
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China.
Bi Q; Zhang L; Zhao Z; Mu X; Zhang M; Wang P
J Med Virol; 2015 Dec; 87(12):2114-21. PubMed ID: 26069229
[TBL] [Abstract][Full Text] [Related]
47. Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population.
Xu HH; Lin A; Chen YH; Dong SS; Shi WW; Yu JZ; Yan WH
BMJ Open; 2017 Jun; 7(6):e014135. PubMed ID: 28601819
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
49. [Human papillomavirus infection and vaccination].
He ZH; Kou ZQ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
[TBL] [Abstract][Full Text] [Related]
50. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of human papillomavirus infection among women with cervical cytological abnormalities in the Zhoupu District, Shanghai City, China, 2014-2019.
Li P; Liu Q; Li W; Liu Z; Xing B; Wu S; Zhou Z; Sun L; Ren H; Li H; Li H
Virol J; 2021 Mar; 18(1):51. PubMed ID: 33685499
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women.
Tang Y; Zheng L; Yang S; Li B; Su H; Zhang LP
Virol J; 2017 Apr; 14(1):84. PubMed ID: 28431558
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
55. Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.
Yang J; Wang W; Wang Z; Wang Z; Wang Y; Wang J; Zhao W; Li D; Liu H; Hao M
Hum Vaccin Immunother; 2020 Jul; 16(7):1645-1652. PubMed ID: 31809222
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China.
Huiyun J; Jie D; Huan W; Yuebo Y; Xiaomao L
J Infect Public Health; 2023 Oct; 16(10):1531-1536. PubMed ID: 37562080
[TBL] [Abstract][Full Text] [Related]
57. Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China.
Xin HN; Li HJ; Li Z; Li XW; Li MF; Zhang HR; Feng BX; Lun WH; Yan HW; Long J; Gao L
Epidemiol Infect; 2017 Oct; 145(13):2838-2847. PubMed ID: 28784189
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study.
Baddal B; Oktay MN; Bostanci A; Yenen MC
BMC Womens Health; 2023 Jun; 23(1):297. PubMed ID: 37270608
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and genotype distribution of high-risk human papillomavirus in 34 420 cases in Yangzhou city, Jiangsu province, China.
Li Y; Liu X; Han C; Ren C
J Med Virol; 2021 Aug; 93(8):5095-5102. PubMed ID: 33847377
[TBL] [Abstract][Full Text] [Related]
60. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
Dillner J; Nygård M; Munk C; Hortlund M; Hansen BT; Lagheden C; Liaw KL; Kjaer SK
Vaccine; 2018 Jun; 36(26):3820-3829. PubMed ID: 29778519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
